Focused Wealth Management, Inc Provectus Biopharmaceuticals, Inc. Transaction History

Focused Wealth Management, Inc

  • $746 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 15, 2018
SELL
$0.06 - $0.08 $555 - $740
-9,250 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$0.03 - $0.08 $277 - $740
9,250 New
9,250 $1,000
Q3 2017

Nov 14, 2017
SELL
$0.02 - $0.03 $244 - $366
-12,205 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
12,205
12,205 $0

Others Institutions Holding PVCT

# of Institutions
7
Shares Held
227K
Call Options Held
0
Put Options Held
0
View Full List

About PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT Quotes by TradingView
  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $54.5M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email